EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -1.849
March 31, 2026 -1.974
December 31, 2025 -1.817
September 30, 2025 -1.093
June 30, 2025 -0.6639
March 31, 2025 -0.1958
December 31, 2024 0.1247
September 30, 2024 -0.6012
June 30, 2024 -0.8903
March 31, 2024 -1.049
December 31, 2023 -1.300
September 30, 2023 -0.9683
June 30, 2023 -0.6227
March 31, 2023 -0.5055
December 31, 2022 1.286
September 30, 2022 0.9816
Date Value
June 30, 2022 0.4719
March 31, 2022 0.193
December 31, 2021 -1.760
September 30, 2021 -1.546
June 30, 2021 -4.080
March 31, 2021 -3.941
December 31, 2020 -3.649
September 30, 2020 -3.817
June 30, 2020 -0.8561
March 31, 2020 -0.6031
December 31, 2019 -0.5602
September 30, 2019 -0.3013
June 30, 2019 -0.218
March 31, 2019 -0.1026
December 31, 2018 0.00

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
MediGene AG --
InflaRx NV -0.6484
BioNTech SE -7.847
Moderna, Inc. -7.985
Intellia Therapeutics, Inc. -3.357